Latest News and Press Releases

SK pharmteco partners with Axle Informatics and the National Institutes of Health (NIH) to advance the development of gene therapies for rare diseases.

SK pharmteco announced that its greenhouse gas (GHG) emissions reduction targets have been officially validated by the Science Based Targets initiative.

SK pharmteco announced today that it will host the "Innovations in Pharmaceutical Manufacturing" Symposium in Cambridge, MA, on April 8.

SK pharmteco integrates Prozomix’s extensive biocatalyst libraries into SK pharmteco’s small-molecule development and manufacturing services.

SK pharmteco reaffirms its three business unit strategy - small molecules, peptides, and viral vectors - with $100 million funding commitment.

SK pharmteco today announced the successful conclusion of a regulatory inspection of its small molecule North America facility in La Porte, Texas.

SK pharmteco today announced the successful CGMP qualification of its manufacturing facility in Corbeil-Essonnes, France.